439 related articles for article (PubMed ID: 18677409)
61. Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling.
Tam J; Szanda G; Drori A; Liu Z; Cinar R; Kashiwaya Y; Reitman ML; Kunos G
Mol Metab; 2017 Oct; 6(10):1113-1125. PubMed ID: 29031713
[TBL] [Abstract][Full Text] [Related]
62. Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.
Tam J; Cinar R; Liu J; Godlewski G; Wesley D; Jourdan T; Szanda G; Mukhopadhyay B; Chedester L; Liow JS; Innis RB; Cheng K; Rice KC; Deschamps JR; Chorvat RJ; McElroy JF; Kunos G
Cell Metab; 2012 Aug; 16(2):167-79. PubMed ID: 22841573
[TBL] [Abstract][Full Text] [Related]
63. Hypoxia training improves hepatic steatosis partly by downregulation of CB1 receptor in obese mice.
Yang Q; Sun S; Liu W; Liu Q; Wang J
Biochem Biophys Res Commun; 2020 May; 525(3):639-645. PubMed ID: 32122652
[TBL] [Abstract][Full Text] [Related]
64. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
[TBL] [Abstract][Full Text] [Related]
65. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.
Lin HY; Yu IC; Wang RS; Chen YT; Liu NC; Altuwaijri S; Hsu CL; Ma WL; Jokinen J; Sparks JD; Yeh S; Chang C
Hepatology; 2008 Jun; 47(6):1924-35. PubMed ID: 18449947
[TBL] [Abstract][Full Text] [Related]
66. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
67. Coordinated regulation of hepatic energy stores by leptin and hypothalamic agouti-related protein.
Warne JP; Varonin JM; Nielsen SS; Olofsson LE; Kaelin CB; Chua S; Barsh GS; Koliwad SK; Xu AW
J Neurosci; 2013 Jul; 33(29):11972-85. PubMed ID: 23864684
[TBL] [Abstract][Full Text] [Related]
68. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
[TBL] [Abstract][Full Text] [Related]
69. Hepatic steatosis and plasma dyslipidemia induced by a high-sucrose diet are corrected by an acute leptin infusion.
Huang W; Dedousis N; O'Doherty RM
J Appl Physiol (1985); 2007 Jun; 102(6):2260-5. PubMed ID: 17363621
[TBL] [Abstract][Full Text] [Related]
70. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
71. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
[TBL] [Abstract][Full Text] [Related]
72. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
73. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.
Kwok A; Zvetkova I; Virtue S; Luijten I; Huang-Doran I; Tomlinson P; Bulger DA; West J; Murfitt S; Griffin J; Alam R; Hart D; Knox R; Voshol P; Vidal-Puig A; Jensen J; O'Rahilly S; Semple RK
Mol Metab; 2020 Oct; 40():101020. PubMed ID: 32439336
[TBL] [Abstract][Full Text] [Related]
74. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
[TBL] [Abstract][Full Text] [Related]
75. Short-term time-restricted feeding during the resting phase is sufficient to induce leptin resistance that contributes to development of obesity and metabolic disorders in mice.
Oishi K; Hashimoto C
Chronobiol Int; 2018 Oct; 35(11):1576-1594. PubMed ID: 30084652
[TBL] [Abstract][Full Text] [Related]
76. Time-restricted feeding mice a high-fat diet induces a unique lipidomic profile.
Mehus AA; Rust B; Idso JP; Hanson B; Zeng H; Yan L; Bukowski MR; Picklo MJ
J Nutr Biochem; 2021 Feb; 88():108531. PubMed ID: 33098972
[TBL] [Abstract][Full Text] [Related]
77. Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity.
Kwon EY; Kim SY; Choi MS
Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060507
[TBL] [Abstract][Full Text] [Related]
78. Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice.
Zhao R; Xiang B; Dolinsky VW; Xia M; Shen GX
J Nutr Biochem; 2021 Sep; 95():108778. PubMed ID: 34004342
[TBL] [Abstract][Full Text] [Related]
79. Arctic berry extracts target the gut-liver axis to alleviate metabolic endotoxaemia, insulin resistance and hepatic steatosis in diet-induced obese mice.
Anhê FF; Varin TV; Le Barz M; Pilon G; Dudonné S; Trottier J; St-Pierre P; Harris CS; Lucas M; Lemire M; Dewailly É; Barbier O; Desjardins Y; Roy D; Marette A
Diabetologia; 2018 Apr; 61(4):919-931. PubMed ID: 29270816
[TBL] [Abstract][Full Text] [Related]
80. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice.
Gruben N; Funke A; Kloosterhuis NJ; Schreurs M; Sheedfar F; Havinga R; Houten SM; Shiri-Sverdlov R; van de Sluis B; Kuivenhoven JA; Koonen DP; Hofker MH
J Diabetes Res; 2015; 2015():956854. PubMed ID: 25815343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
